Cooper Companies (The) (COO) cash flow statement
TrendArc score 43 of 100 · Health 6.0 · Momentum 3.8 · Moat 5.8 · scored Nov 17, 2026 · How the score works
Free cash flow, fiscal year to October 31, 2025
$434 million
up 50.5% from the year before
Cooper Companies (The) generated $434 million of free cash flow in the fiscal year to October 2025: $796 million of cash from operations less $362 million of capital spending. That was 10.6% of revenue, against 7.4% the year before. Over the last four quarters, to July 31, 2026, it was $678 million.
What stands out
- Net share repurchases of $299 million came to 69% of free cash flow in the fiscal year to October 2025.
Each sentence is written by a fixed rule from the figures on this page.
Free cash flow and net income, the last 10 fiscal years
Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.
Where the cash wentFiscal year to October 31, 2025
- Cash from operations 0.80
- Capital spending -0.36
- Free cash flow 0.43
- Businesses bought and sold, net -0.01
- Net share repurchases -0.30
- Debt and other -0.12
- Net change in cash 0.00
In billions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.
Cash flow statement, the last 10 fiscal years
| Fiscal year to | Last 4 quarters to Jul 2026 | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||
| Net income | 0.37 | 0.39 | 0.29 | 0.39 | 2.94 | 0.24 | 0.47 | 0.14 | 0.37 | 0.27 | |
| Depreciation and amortisation | 0.42 | 0.41 | 0.41 | 0.38 | 0.34 | 0.32 | 0.28 | 0.28 | 0.19 | 0.20 | |
| Stock-based pay | — | 0.07 | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.01 |
| Working capital and other items | -0.07 | -0.17 | -0.16 | -0.13 | -2.59 | -0.11 | -0.07 | 0.21 | 0.00 | 0.03 | |
| Cash from operations | 1.03 | 0.80 | 0.71 | 0.61 | 0.69 | 0.74 | 0.49 | 0.71 | 0.67 | 0.59 | 0.51 |
| Investing activities | |||||||||||
| Capital spending | -0.36 | -0.36 | -0.42 | -0.39 | -0.24 | -0.21 | -0.31 | -0.29 | -0.19 | -0.13 | -0.15 |
| Businesses bought and sold, net | -0.01 | -0.34 | -0.06 | -1.59 | -0.24 | -0.05 | -0.06 | -1.32 | -0.25 | -0.27 | |
| Investments bought and sold, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from investing | -0.37 | -0.76 | -0.45 | -1.83 | -0.45 | -0.36 | -0.35 | -1.52 | -0.38 | -0.42 | |
| Financing activities | |||||||||||
| Debt issued or repaid, net | -0.08 | 0.01 | -0.18 | 1.28 | -0.31 | -0.04 | -0.20 | 0.85 | -0.16 | -0.03 | |
| Shares issued less bought back | -0.66 | -0.30 | 0.03 | 0.01 | -0.08 | 0.00 | -0.05 | -0.15 | 0.00 | -0.06 | 0.01 |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other financing | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Cash from financing | -0.43 | 0.04 | -0.17 | 1.19 | -0.31 | -0.10 | -0.35 | 0.84 | -0.23 | 0.00 | |
| Net change in cash | 0.00 | -0.01 | -0.02 | 0.04 | -0.02 | 0.03 | 0.01 | -0.01 | -0.01 | 0.08 | |
| Free cash flow | |||||||||||
| Free cash flow | 0.68 | 0.43 | 0.29 | 0.21 | 0.45 | 0.52 | 0.18 | 0.42 | 0.48 | 0.47 | 0.36 |
| Free cash flow margin | 16.0% | 10.6% | 7.4% | 6.0% | 13.6% | 17.9% | 7.2% | 15.9% | 18.8% | 21.8% | 18.2% |
| Free cash flow per share | $2.17 | $1.44 | $1.08 | $2.27 | $2.63 | $0.89 | $2.11 | $2.42 | $2.36 | $1.82 | |
Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.
Cooper Companies (The) against its peers
| Company | Fiscal year to | Free cash flow | Free cash flow margin |
|---|---|---|---|
| Bio-TechneTECH | Jun 2026 | $263M | 21.7% |
| RevvityRVTY | Dec 2025 | $509M | 17.8% |
| SterisSTE | Mar 2026 | $983M | 16.6% |
| InsuletPODD | Dec 2025 | $350M | 12.9% |
| Charles River LaboratoriesCRL | Dec 2025 | $518M | 12.9% |
| Align TechnologyALGN | Dec 2025 | $491M | 12.2% |
| Cooper Companies (The)COO | Oct 2025 | $434M | 10.6% |
| Baxter InternationalBAX | Dec 2025 | $323M | 2.9% |
| Peer median | 12.9% |
Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.
Next
Follow Cooper Companies (The) with a free account.
A watchlist, price alerts and saved chart layouts. No card needed.
Sign up freeNo forecast, no recommendation. This page describes Cooper Companies (The) from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.
The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.